AACR 2026 现场信号· @ · X·· 2026-04-22Score60
Body · original
Live from #AACR26: We’re presenting new data highlighting the efficacy and safety of our ROS1 inhibitor in TKI-naive and TKI-pretreated patients with ROS1+ #NSCLC. Learn more: https://t.co/OWMTnr4v4F. https://t.co/WoWRj7vNGD
Heat 3 · 3 likes · 0 replies · 0 reposts
Source: AACR 2026 现场信号 · x.com